Philip Troke

Philip Troke is currently the Global Medical Asset Lead for adult cholestasis at Ipsen, a position they have held since 2025. They have extensive experience in the pharmaceutical industry, including roles such as Medical Science Liaison Manager at Janssen and Senior Scientist at Pfizer. Previously, Philip also served as an Associate Director of Medical Affairs at Gilead Sciences and held multiple director-level positions in medical affairs at various organizations. Philip completed a postdoctoral fellowship at both Harvard Medical School and Novartis Institutes for Biomedical Research.